These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2863632)

  • 1. Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus.
    Schernthaner G; Banatvala JE; Scherbaum W; Bryant J; Borkenstein M; Schober E; Mayr WR
    Lancet; 1985 Sep; 2(8456):630-2. PubMed ID: 2863632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.
    King ML; Shaikh A; Bidwell D; Voller A; Banatvala JE
    Lancet; 1983 Jun; 1(8339):1397-9. PubMed ID: 6134178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.
    Banatvala JE; Bryant J; Schernthaner G; Borkenstein M; Schober E; Brown D; De Silva LM; Menser MA; Silink M
    Lancet; 1985 Jun; 1(8443):1409-12. PubMed ID: 2861361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus.
    D'Alessio DJ
    Am J Epidemiol; 1992 Jun; 135(12):1331-8. PubMed ID: 1324601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between Coxsackie-B-virus-specific IgG responses and genetic factors (HLA-DR, GM, KM) in insulin-dependent diabetes mellitus.
    Field LL; McArthur RG; Shin SY; Yoon JW
    Diabetes Res; 1987 Dec; 6(4):169-73. PubMed ID: 2834133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackie B virus antibody responses in juvenile-onset diabetes mellitus.
    Ray CG; Palmer JP; Crossley JR; Williams RH
    Clin Endocrinol (Oxf); 1980 Apr; 12(4):375-8. PubMed ID: 6247107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic alpha cell autoantibodies and glucagon response to arginine.
    Winter WE; Maclaren NK; Riley WJ; Unger RH; Neufeld M; Ozand PT
    Diabetes; 1984 May; 33(5):435-7. PubMed ID: 6373451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in Indian-Asians with insulin-dependent diabetes in the UK.
    Odugbesan O; Fletcher JA; Sanders A; Bradwell AR; Botazzo GF; Barnett AH
    Postgrad Med J; 1988 May; 64(751):357-60. PubMed ID: 3059339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes.
    Mertens T; Grüneklee D; Eggers HJ
    Eur J Pediatr; 1983 Sep; 140(4):293-4. PubMed ID: 6313373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study.
    Eberhardt MS; Wagener DK; Orchard TJ; LaPorte RE; Cavender DE; Rabin BS; Atchison RW; Kuller LH; Drash AL; Becker DJ
    Diabetes; 1985 Dec; 34(12):1247-52. PubMed ID: 2998911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients.
    Nicoletti F; Scalia G; Lunetta M; Condorelli F; Di Mauro M; Barcellini W; Stracuzzi S; Pagano M; Meroni PL
    Clin Immunol Immunopathol; 1990 Apr; 55(1):139-47. PubMed ID: 2155076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects.
    Bruserud O; Jervell J; Thorsby E
    Diabetologia; 1985 Jul; 28(7):420-6. PubMed ID: 2995183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes and Coxsackie virus infection.
    Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
    Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible role of Coxsackie A and echo viruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis.
    Frisk G; Nilsson E; Tuvemo T; Friman G; Diderholm H
    J Infect; 1992 Jan; 24(1):13-22. PubMed ID: 1312561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
    Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
    Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases.
    El-Hagrassy MM; Banatvala JE; Coltart DJ
    Lancet; 1980 Nov; 2(8205):1160-2. PubMed ID: 6107769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackie virus B antibodies are increased in HLA DR3-MICA5.1 positive type 1 diabetes patients in the Linköping region of Sweden.
    Gupta M; Nikitina-Zake L; Landin-Olsson M; Kockum I; Sanjeevi CB
    Hum Immunol; 2003 Sep; 64(9):874-9. PubMed ID: 12941542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.